Total Payments
$7,330
2024 Payments
$7,121
Companies
9
Transactions
23
Medicare Patients
1,949
Medicare Billing
$212,458
Payment Breakdown by Category
Consulting$5,824 (79.5%)
Travel$973.87 (13.3%)
Food & Beverage$532.20 (7.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $5,824 | 1 | 79.5% |
| Travel and Lodging | $973.87 | 4 | 13.3% |
| Food and Beverage | $532.20 | 18 | 7.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $7,121 | 9 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $55.91 | 4 | $0 (2020) |
| Daiichi Sankyo Inc. | $27.60 | 2 | $0 (2018) |
| GlaxoSmithKline, LLC. | $27.40 | 2 | $0 (2019) |
| PFIZER INC. | $25.93 | 2 | $0 (2020) |
| Novo Nordisk Inc | $22.05 | 1 | $0 (2020) |
| Shire North American Group Inc | $20.63 | 1 | $0 (2018) |
| Lilly USA, LLC | $18.75 | 1 | $0 (2017) |
| Amgen Inc. | $11.08 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,121 | 9 | GENZYME CORPORATION ($7,121) |
| 2020 | $59.89 | 4 | AstraZeneca Pharmaceuticals LP ($25.66) |
| 2019 | $58.79 | 4 | AstraZeneca Pharmaceuticals LP ($30.25) |
| 2018 | $35.54 | 2 | Shire North American Group Inc ($20.63) |
| 2017 | $55.13 | 4 | Lilly USA, LLC ($18.75) |
All Payment Transactions
23 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/20/2024 | GENZYME CORPORATION | KEVZARA (Biological) | Consulting Fee | Cash or cash equivalent | $5,824.00 | General |
| Category: Rheumatology | ||||||
| 01/20/2024 | GENZYME CORPORATION | KEVZARA (Biological) | Travel and Lodging | In-kind items and services | $473.13 | General |
| Category: Rheumatology | ||||||
| 01/20/2024 | GENZYME CORPORATION | KEVZARA (Biological) | Travel and Lodging | In-kind items and services | $276.20 | General |
| Category: Rheumatology | ||||||
| 01/20/2024 | GENZYME CORPORATION | KEVZARA (Biological) | Travel and Lodging | In-kind items and services | $204.54 | General |
| Category: Rheumatology | ||||||
| 01/20/2024 | GENZYME CORPORATION | KEVZARA (Biological) | Food and Beverage | In-kind items and services | $149.99 | General |
| Category: Rheumatology | ||||||
| 01/20/2024 | GENZYME CORPORATION | KEVZARA (Biological) | Food and Beverage | In-kind items and services | $78.58 | General |
| Category: Rheumatology | ||||||
| 01/20/2024 | GENZYME CORPORATION | KEVZARA (Biological) | Food and Beverage | In-kind items and services | $54.99 | General |
| Category: Rheumatology | ||||||
| 01/20/2024 | GENZYME CORPORATION | KEVZARA (Biological) | Food and Beverage | In-kind items and services | $39.29 | General |
| Category: Rheumatology | ||||||
| 01/20/2024 | GENZYME CORPORATION | KEVZARA (Biological) | Travel and Lodging | In-kind items and services | $20.00 | General |
| Category: Rheumatology | ||||||
| 07/16/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: Diabetes | ||||||
| 04/21/2020 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Respiratory | ||||||
| 02/25/2020 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $12.16 | General |
| Category: Respiratory | ||||||
| 01/16/2020 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $12.18 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 10/29/2019 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $10.80 | General |
| Category: Respiratory | ||||||
| 10/28/2019 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: Respiratory | ||||||
| 10/09/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 06/13/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), ANORO | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: RESPIRATORY | ||||||
| 07/10/2018 | Shire North American Group Inc | NATPARA (Drug) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: INTERNAL MEDICINE | ||||||
| 02/06/2018 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Anemia | ||||||
| 08/08/2017 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: Anemia | ||||||
| 06/19/2017 | Lilly USA, LLC | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Diabetes | ||||||
| 04/27/2017 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $11.08 | General |
| Category: Endocrinology | ||||||
| 03/29/2017 | GlaxoSmithKline, LLC. | BREO (Drug), ANORO, INCRUSE | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 453 | 733 | $129,181 | $56,642 |
| 2022 | 4 | 469 | 803 | $160,110 | $60,613 |
| 2021 | 4 | 456 | 838 | $184,041 | $63,496 |
| 2020 | 7 | 571 | 686 | $83,329 | $31,707 |
Total Patients
1,949
Total Services
3,060
Medicare Billing
$212,458
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 198 | 456 | $58,294 | $28,274 | 48.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 142 | 142 | $52,540 | $17,999 | 34.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 33 | 50 | $8,900 | $4,835 | 54.3% |
| 91322 | Sarscov2 vac 50 mcg/0.5ml im | Office | 2023 | 21 | 21 | $4,347 | $3,003 | 69.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 37 | 42 | $3,780 | $1,644 | 43.5% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 22 | 22 | $1,320 | $886.82 | 67.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 227 | 529 | $77,672 | $30,185 | 38.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 170 | 170 | $63,240 | $21,705 | 34.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 54 | 81 | $16,829 | $7,844 | 46.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 18 | 23 | $2,369 | $880.35 | 37.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 233 | 586 | $103,358 | $36,875 | 35.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 133 | 133 | $55,461 | $17,262 | 31.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 67 | 93 | $21,888 | $8,253 | 37.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 23 | 26 | $3,334 | $1,105 | 33.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 146 | 210 | $26,861 | $9,105 | 33.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 117 | 140 | $17,971 | $8,559 | 47.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 95 | 109 | $9,592 | $2,835 | 29.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 41 | 41 | $7,011 | $2,605 | 37.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 53 | 59 | $5,585 | $2,305 | 41.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 25 | 26 | $4,446 | $1,737 | 39.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 15 | 15 | $5,070 | $1,733 | 34.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 44 | 48 | $3,888 | $1,679 | 43.2% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 15 | 17 | $2,023 | $830.08 | 41.0% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Facility | 2020 | 20 | 21 | $882.00 | $319.74 | 36.3% |
About Dr. Robert Hejl, MD
Dr. Robert Hejl, MD is a Internal Medicine healthcare provider based in Albany, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1629146030.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Hejl, MD has received a total of $7,330 in payments from pharmaceutical and medical device companies, with $7,121 received in 2024. These payments were reported across 23 transactions from 9 companies. The most common payment nature is "Consulting Fee" ($5,824).
As a Medicare-enrolled provider, Hejl has provided services to 1,949 Medicare beneficiaries, totaling 3,060 services with total Medicare billing of $212,458. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine, Internal Medicine
- Location Albany, OR
- Active Since 12/01/2006
- Last Updated 11/03/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1629146030
Products in Payments
- KEVZARA (Biological) $7,121
- FASENRA (Drug) $30.25
- INJECTAFER (Drug) $27.60
- CHANTIX (Drug) $25.93
- SYMBICORT (Drug) $25.66
- Ozempic (Drug) $22.05
- NATPARA (Drug) $20.63
- TRADJENTA (Drug) $18.75
- TRELEGY ELLIPTA (Drug) $14.79
- BREO (Drug) $12.61
- Prolia (Biological) $11.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Albany
Dr. Scott Beegle, M.d, M.D
Internal Medicine — Payments: $1.9M
Internal Medicine $1.9M
Frank Cortazar, Md, MD
Internal Medicine — Payments: $225,694
Internal Medicine $225,694
Jill Braverman-Panza, Md, MD
Internal Medicine — Payments: $176,760
Internal Medicine $176,760
Ann Michalek, Md, MD
Internal Medicine — Payments: $79,945
Internal Medicine $79,945
Dr. Nathaniel Steiger, M.d, M.D
Internal Medicine — Payments: $28,637
Internal Medicine $28,637
Mandeep Sidhu, M.d.-M.b.a, M.D.-M.B.A
Internal Medicine — Payments: $21,249
Internal Medicine $21,249